# Session Analysis: session-20260322-154446

## Pipeline Metrics
- Generated: 13 hypotheses (7 cycle 1, 6 cycle 2)
- Survived critique: 9 (69% survival rate)
- Passed Quality Gate: 1 (33% pass rate — H2.3-E)
- Passed Cross-Model Validation: 1 (H2.3-E with critical corrections)
- Kill rate: 42.9% (healthy quality control)
- Session health: **SUCCESS**
- Duration: 4.5 hours (2026-03-22T14:45:27Z → 2026-03-22T19:32:00Z)

## Strategy Performance: tool_repurposing (First Primary Test)
- **Scout identification**: 8.5/10 (highest unselected target from previous session)
- **Target quality**: DISJOINT confirmed (0 cross-citations geochemistry ↔ pharmaceutical ASD)
- **Bridge concepts**: TST rate law, PHREEQC modeling, passivation layer kinetics, saturation index
- **Generation success**: 13 hypotheses with rich quantitative detail
- **Critique survival**: 69% (above pipeline average of ~50-60%)
- **Quality Gate performance**: 33% pass rate (1/3 evolved hypotheses passed)

**Assessment**: **PROMISING** — comparable performance to established strategies, but reveals need for enhanced biological constraint verification in tool transfer applications.

## This Session's Kill Patterns

### New Failure Modes Identified
1. **Fabricated polymer interaction claims** (H2.4-E):
   - Claimed: "Polymers preferentially adsorb to crystalline nuclei but NOT to LLPS droplets"
   - Reality: HPMCAS-HF distributes extensively into drug-rich LLPS phase (Mol Pharmaceutics 2022, NMR evidence)
   - **Pattern**: Tool transfer hypotheses prone to inventing interactions not verified in target domain

2. **Activation volume misapplication** (H2.1-E):
   - Claimed: Pressure kinetics dominate via exp(-dV*P/RT) mechanism in ASD dissolution
   - Reality: Polymer-containing ASD shows NO pressure dependence due to gel layer formation
   - **Pattern**: Mathematical frameworks from Field A may not apply when Field C has structural differences (amorphous vs crystalline, polymer-modified vs pure compound)

3. **Autocatalytic mechanism sign error** (H2.3-E):
   - Claimed: HPMCAS dissolution raises local pH creating positive feedback
   - Reality: HPMCAS is acidic polymer — dissolution lowers pH (negative feedback)
   - **Pattern**: Cross-model validation catches sign errors missed by single-model evaluation

## Bridge Type Analysis: Geochemical Tool Transfer

**Performance**: 1 PASS, 2 FAIL from 3 evolved hypotheses

**What Worked**:
- TST rate law mathematical structure (r = k·(1-Q/K)) applicable to both systems
- Saturation index concept (SI = log(Q/K)) maps to supersaturation in pharmaceutical systems
- Three-region dissolution framework provides useful organizing structure

**What Failed**:
- Direct activation volume transfer without accounting for polymer matrix effects
- Assumption that pharmaceutical polymers behave like inorganic glasses
- Geochemical dual-buffer mechanism doesn't mechanistically derive pharmaceutical behavior

**Insight**: Geochemical tools transfer at the level of reaction-transport mathematics (Nernst-Planck, Stefan moving-boundary) but require independent grounding in target domain physics. The analogy is productive as discovery heuristic, not mechanistic proof.

## Cross-Model Validation Insights

**GPT-5.4 Focus**: Empirical plausibility, mechanism verification, experimental feasibility
**Gemini 3.1 Pro Focus**: Mathematical formalism, structural analogies, novel predictions

**Key Convergences**:
- Both identified autocatalytic sign error independently
- Both agreed geochemical bridge is inspirational, not derivational
- Both confirmed sigmoidal switching behavior is mechanistically sound

**Novel Prediction Generated**: Gemini derived diffusivity-ratio test not in original hypothesis — bulk buffer diffusivity should modulate apparent pH_switch of ASD dissolution.

**Meta-Learning**: Divergent evaluation axes (empirical vs structural) create productive tension for hypothesis refinement.

## New Insights from This Session

1. **Tool repurposing strategy viability**: First primary test shows promise but requires enhanced constraint verification for cross-domain applications.

2. **Geochemical → pharmaceutical bridge characteristics**: Mathematical frameworks transfer successfully; mechanistic details require independent validation in biological/pharmaceutical systems.

3. **Cross-model validation error detection**: Two independent models catch sign errors and fabricated claims more reliably than single-model evaluation.

4. **Domain infrastructure impact**: Pharmaceutical domain's rich database coverage enables thorough claim verification; hypotheses in well-covered domains face higher groundedness standards.

## Recommendations for Pipeline Improvement

**For Scout**:
- tool_repurposing confirmed as viable strategy; add to regular rotation
- Continue prioritizing DISJOINT targets (this session's success confirms meta-learning insight)

**For Generator**:
- Add "biological constraint pre-check" for tool transfer hypotheses
- Verify polymer/matrix effects don't invalidate borrowed mechanisms
- Cross-check acid/base properties before claiming pH feedback effects

**For Quality Gate**:
- Enhanced scrutiny for tool transfer bridges — verify domain-specific constraints
- Per-claim verification particularly critical when bridging physical sciences to biology

**For Cross-Model Validator**:
- Continue dual-axis evaluation (empirical vs structural) — divergence is productive
- Integrate novel predictions generated by external models into hypothesis refinement

## Session Outcome
**SUCCESS** — Pipeline generated 1 high-quality hypothesis with clear experimental pathway, identified 2 critical failure modes for meta-learning, and validated tool_repurposing as a productive strategy with specific improvement guidelines.